AI-designed antibodies with Germinal

TL;DR - A Nature Methods item (published 06 Aug 2026) covering "Germinal," an AI approach for computationally designing antibodies. Only the title and metadata are available, so this is an inference-level summary rather than a report of results.

• Positions generative/structure-based AI in the antibody design pipeline — i.e., proposing binder sequences computationally rather than relying solely on animal immunization or display-library screening.
• Published in Nature Methods, indicating the emphasis is on a reusable method/tool for the community rather than a single biological finding; such entries are typically accompanied by wet-lab validation of designed binders.
• Sits in the protein-design branch of AI for biology (alongside structure prediction and inverse-folding models), with direct relevance to therapeutic and diagnostic reagent discovery.
• Caveat: no abstract, benchmarks, success rates, or affinity/expression data were retrievable, so no performance claims can be verified here — consult the article for specifics.